Evidence map›Paper›PMID 32936778›Full record

ArticleJournal of the American Society of Nephrology : JASN2020

A Single Point-in-Time eGFR Is Not Associated with Increased Risk of Dementia in the Elderly.

Aditi Gupta, Jeffrey M Burns

Abstract readLetterComment
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Mild to moderate decrease in eGFR and cognitive decline in older adults.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  7. Article
  8. Insights into Cognitive Brain Health in Chronic Kidney Disease.Gerontology & geriatrics : research · 2022
    Article
  9. Article
  10. Authors' Reply.Journal of the American Society of Nephrology : JASN · 2020
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Aditi GuptaDivision of Nephrology and Hypertension, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas agupta@kumc.edu.ORCID 0000-0002-6286-802X
Jeffrey M BurnsUniversity of Kansas Alzheimer's Disease Center, Fairway, Kansas.

Funding

RADx-UP: Improving the Response of Local Urban and Rural Communities to Disparities in Covid-19 TestingUL1TR002366 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mario Castro, JAMES STEVEN LEEDER · 2017 to 2026
$44.3M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SWERDLOW, RUSSELL H. · 2011 to 2020
$16.6M
Pilot and Feasibility CoreP30DK106912 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CALVET, JAMES P · 2015 to 2019
$5.5M
Cognitive Impairment in End Stage Renal DiseaseK23AG055666 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI GUPTA, ADITI · 2017 to 2022
$1.2M
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive DeclineR61AG068483 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BURNS, JEFFREY MURRAY, GUPTA, ADITI · 2020 to 2020
$761k
NCATS NIH HHS UL1 TR002366NIA NIH HHS K23 AG055666NIA NIH HHS P30 AG035982NIA NIH HHS R61 AG068483NIDDK NIH HHS P30 DK106912
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cognitive DysfunctionDementiaHypertensionKidney DiseasesAgedBlood PressureErbB ReceptorsHumansEGFR protein, humanErbB Receptorscognitiondecline in eGFRdementiaeGFR

Identifiers

PMID32936778
PMCPMC7790220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.